HiLIFE supports commercialization of research
In December 2017, Helsinki Institute of Life Science HiLIFE divided the total of € 347,900 Proof of Concept Grants between seven projects to accelerate the commercialization of research findings and development of novel technologies. The deadlines for 2018 applications are 5 March, 1 June, and 15 October.

HiLIFE Proof of Concept (HiPoC) Grants  can be applied by University of Helsinki life science researchers with a doctorate who consider or are already involved in an invention disclosure to Helsinki Innovation Services, or listed as inventors on a pending patent application owned by University of Helsinki.

More information on how to apply can be found at: www.helsinki.fi/en/helsinki-institute-of-life-science/hipoc-proof-of-concept-grants. In 2018, the deadlines for applications are 5 March, 1 June, and 15 October.

"We are happy to see an increasing interest in these grants," says Pia Runeberg-Roos from HiLIFE.

The first HiPoC Grants were awarded in October 2017 (see the list of recipients), and in December the Grant was awarded to the following researchers and projects:

Giuseppe Balistreri, 48516 euro 
Development of a novel virus Modified in vitro Translation system (vMiT)

Susanna Fagerholm, 50000 euro
THE DENVAX PROJECT - manipulating dendritic cells to improve cancer immunotherapy

Johan Lundin, 50000 euro
Proof-of-concept studies related to a mobile digital microscope scanner (MoMic) towards a product for point-of-care diagnostics

Ari Löytynoja, 49380 euro
Data visualization library for web publishing

Timo Myöhänen, 50000 euro
Prolyl oligopeptidase ligands - a possibility for a common drug therapy for several neurodegenerative diseases?

Päivi Saavalainen, 50000 euro
Novel cell barcoding method for genomic and transcriptomic profiling of single cells in suspensions and tissues in situ

Merja Voutilainen, 50000 euro 
Next generation CDNF in the treatment of Parkinson’s disease

For more information, contact Pia Runeberg-Roos, pia.runeberg@helsinki.fi